Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
At-home ULTRA Study in Rheumatoid Arthritis
NCT07163221Active, not recruiting
- Sponsor
- SecondWave Systems
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) (3 arms), sponsored by SecondWave Systems. Primary endpoint: Disease Activity Score 28-joint count C reactive protein at 12 weeks. Started Nov 2025; status: active, not recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07163221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163221.